Search

Scott Dodds

Examiner (ID: 5800, Phone: (571)270-7653 , Office: P/1746 )

Most Active Art Unit
1746
Art Unit(s)
1791, 1746
Total Applications
996
Issued Applications
635
Pending Applications
97
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7328472 [patent_doc_number] => 20040253665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them' [patent_app_type] => new [patent_app_number] => 10/819941 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253665.pdf [firstpage_image] =>[orig_patent_app_number] => 10819941 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/819941
Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them Apr 7, 2004 Abandoned
Array ( [id] => 5631011 [patent_doc_number] => 20060147480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant' [patent_app_type] => utility [patent_app_number] => 10/551840 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14824 [patent_no_of_claims] => 143 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147480.pdf [firstpage_image] =>[orig_patent_app_number] => 10551840 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551840
Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant Apr 1, 2004 Issued
Array ( [id] => 7161604 [patent_doc_number] => 20050084943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'New conditions for reactions mediated by yeast' [patent_app_type] => utility [patent_app_number] => 10/814891 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4576 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084943.pdf [firstpage_image] =>[orig_patent_app_number] => 10814891 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/814891
Conditions for reactions mediated by yeast Mar 30, 2004 Issued
Array ( [id] => 7351048 [patent_doc_number] => 20040248769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Enzyme inhibitors for inactivating allergens' [patent_app_type] => new [patent_app_number] => 10/487657 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4469 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248769.pdf [firstpage_image] =>[orig_patent_app_number] => 10487657 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/487657
Enzyme inhibitors for inactivating allergens Feb 19, 2004 Abandoned
Array ( [id] => 5700615 [patent_doc_number] => 20060217300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Analogues of glp-1' [patent_app_type] => utility [patent_app_number] => 10/546303 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25444 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217300.pdf [firstpage_image] =>[orig_patent_app_number] => 10546303 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546303
Analogues of glp-1 Feb 16, 2004 Abandoned
Array ( [id] => 7432204 [patent_doc_number] => 20040162242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/778756 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21221 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162242.pdf [firstpage_image] =>[orig_patent_app_number] => 10778756 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778756
Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof Feb 12, 2004 Issued
Array ( [id] => 7326867 [patent_doc_number] => 20040253226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases' [patent_app_type] => new [patent_app_number] => 10/777998 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15233 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253226.pdf [firstpage_image] =>[orig_patent_app_number] => 10777998 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777998
Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases Feb 11, 2004 Abandoned
Array ( [id] => 74625 [patent_doc_number] => 07750117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Methods for heat-stabilizing proteins with specific binding activities' [patent_app_type] => utility [patent_app_number] => 10/777825 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3106 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750117.pdf [firstpage_image] =>[orig_patent_app_number] => 10777825 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777825
Methods for heat-stabilizing proteins with specific binding activities Feb 10, 2004 Issued
Array ( [id] => 4872705 [patent_doc_number] => 20080199439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods' [patent_app_type] => utility [patent_app_number] => 10/777946 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9834 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199439.pdf [firstpage_image] =>[orig_patent_app_number] => 10777946 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/777946
IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods Feb 10, 2004 Abandoned
Array ( [id] => 668519 [patent_doc_number] => 07094760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Peptides for treatment of inflammation and shock' [patent_app_type] => utility [patent_app_number] => 10/773229 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10277 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094760.pdf [firstpage_image] =>[orig_patent_app_number] => 10773229 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773229
Peptides for treatment of inflammation and shock Feb 8, 2004 Issued
Array ( [id] => 7351289 [patent_doc_number] => 20040248808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Methods for preventing mitochondrial permeability transition' [patent_app_type] => new [patent_app_number] => 10/771232 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11290 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248808.pdf [firstpage_image] =>[orig_patent_app_number] => 10771232 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771232
Methods for preventing mitochondrial permeability transition Feb 2, 2004 Issued
Array ( [id] => 7155892 [patent_doc_number] => 20050026840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics' [patent_app_type] => utility [patent_app_number] => 10/764288 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15369 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026840.pdf [firstpage_image] =>[orig_patent_app_number] => 10764288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/764288
Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics Jan 22, 2004 Issued
Array ( [id] => 7325042 [patent_doc_number] => 20040138110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Inhibitors of the urokinase receptor' [patent_app_type] => new [patent_app_number] => 10/756289 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5414 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138110.pdf [firstpage_image] =>[orig_patent_app_number] => 10756289 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/756289
Inhibitors of the urokinase receptor Jan 13, 2004 Abandoned
Array ( [id] => 6972520 [patent_doc_number] => 20050038230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Linear and cyclic melanocortin receptor-specific peptides' [patent_app_type] => utility [patent_app_number] => 10/756212 [patent_app_country] => US [patent_app_date] => 2004-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12236 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038230.pdf [firstpage_image] =>[orig_patent_app_number] => 10756212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/756212
Linear and cyclic melanocortin receptor-specific peptides Jan 11, 2004 Issued
Array ( [id] => 7424124 [patent_doc_number] => 20040208824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/742634 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61824 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208824.pdf [firstpage_image] =>[orig_patent_app_number] => 10742634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/742634
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof Dec 21, 2003 Abandoned
Array ( [id] => 7424124 [patent_doc_number] => 20040208824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/742634 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 61824 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208824.pdf [firstpage_image] =>[orig_patent_app_number] => 10742634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/742634
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof Dec 21, 2003 Abandoned
Array ( [id] => 679973 [patent_doc_number] => 07084112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Activated polyethylene glycol compounds' [patent_app_type] => utility [patent_app_number] => 10/741496 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8380 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084112.pdf [firstpage_image] =>[orig_patent_app_number] => 10741496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/741496
Activated polyethylene glycol compounds Dec 18, 2003 Issued
Array ( [id] => 5754607 [patent_doc_number] => 20060223756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Endothelial cell specifically binding peptides' [patent_app_type] => utility [patent_app_number] => 10/537847 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23772 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223756.pdf [firstpage_image] =>[orig_patent_app_number] => 10537847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/537847
Endothelial cell specifically binding peptides Dec 16, 2003 Abandoned
Array ( [id] => 7675721 [patent_doc_number] => 20040126397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Use of the neurotoxic component of a botulinum toxin for treating various disorders and conditions and associated pain' [patent_app_type] => new [patent_app_number] => 10/726904 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5514 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126397.pdf [firstpage_image] =>[orig_patent_app_number] => 10726904 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/726904
Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle Dec 1, 2003 Issued
Array ( [id] => 7148106 [patent_doc_number] => 20040170625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives' [patent_app_type] => new [patent_app_number] => 10/714405 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2746 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170625.pdf [firstpage_image] =>[orig_patent_app_number] => 10714405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/714405
Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives Nov 16, 2003 Abandoned
Menu